Chesley Taft & Associates’s Xylem XYL Stock Holding History
Bought
Maintained
Sold
Other funds holding XYL
LMFP
DC
AIM
CTB
SFA
AV
OIAM
CF
Chesley Taft & Associates's XYL Position: Q2 2026 in Review
Chesley Taft & Associates increased its Xylem (XYL) stake by 0.52% in Q2 2026, buying an estimated $9.12K and bringing the position to 15,235 shares worth $1.8M. The position accounts for 0.07% of the portfolio, ranked #173.
Chesley Taft & Associates first reported a position in XYL in Q1 2020 and has held it in 26 quarters since. The position peaked at $2.18M in Q3 2025. 146 funds tracked by Wall St. Rank hold XYL as of Q2 2026.
- Chesley Taft & Associates held 15,235 shares of Xylem worth $1.8M as of Q2 2026.
- Chesley Taft & Associates bought 79 Xylem shares in Q2 2026, an estimated $9.12K.
- Xylem made up 0.07% of Chesley Taft & Associates's portfolio in Q2 2026, its #173 holding.
- Chesley Taft & Associates first reported a position in Xylem in Q1 2020 and has held it in 26 quarters since.
- Chesley Taft & Associates's Xylem position peaked at $2.18M in Q3 2025.
- 146 funds tracked by Wall St. Rank held Xylem as of Q2 2026.
Based on Chesley Taft & Associates's 13F filing for Q2 2026, filed 8 Jul 2026.